Compound 2136
Identifiers
- Canonical SMILES:
Cc1nc(-c2c[nH]c(=O)c(Cl)c2)n(n1)-c1ccc(F)cc1
- IUPAC name:
3-chloro-5-[1-(4-fluorophenyl)-3-methyl-1H-1,2,4-triazol-5-yl]-1,2-dihydropyridin-2-one
- InChi:
InChI=1S/C14H10ClFN4O/c1-8-18-13(9-6-12(15)14(21)17-7-9)20(19-8)11-4-2-10(16)3-5-11/h2-7H,1H3,(H,17,21)
- InChiKey:
ZALGEOPJUDTSFF-UHFFFAOYSA-N
External links
![]() 136014790 |
![]() CHEMBL2436004 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 304.05 g/mol | |||
HBA | 5 | |||
HBD | 1 | |||
HBA + HBD | 6 | |||
AlogP | 2.96 | |||
TPSA | 59.81 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5503 | Deferasirox | DB01609 | |
0.4647 | 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID | DB07852 | |
0.4140 | BOS172722 | DB15498 | |
0.4066 | N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine | DB07584 | |
0.4042 | Selonsertib | DB14916 | |
0.3963 | Ralimetinib | DB11787 | |
0.3779 | Miransertib | DB14982 | |
0.3750 | Dovitinib | DB05928 | |
0.3744 | Lumiflavin | DB04726 | |
0.3728 | Dilmapimod | DB12140 | |
0.3714 | CHIR-124 | DB06852 | |
0.3706 | Ganetespib | DB12047 | |
0.3660 | Vactosertib | DB15310 | |
0.3648 | CC-115 | DB12740 | |
0.3640 | Riboflavin | DB00140 |